Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous platelet-poor plasma to prevent bronchopleural fistula after lung resection
2012-000397-30Phase 2Active
- Sponsor
- Fundación Canaria de Investigación Sanitaria
- Start
- Oct 2012
- Modality
- Peripheral Blood HSCs → Hematopoietic Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2 trial of platelet-poor plasma in bronchopleural fistula (BPF), sponsored by Fundación Canaria de Investigación Sanitaria. Primary endpoint: Reduction in bronchopleural fistula incidence. Started Oct 2012; status: active.
02
Drugs
platelet-poor plasma
03
Conditions
bronchopleural fistula (BPF)
Beyond the preview
Go deeper on 2012-000397-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000397-30.